Radiation Oncology Market Size to grow by USD 1941.2 million between 2024-2028
According to a research report “ Radiation Oncology Market” by Type (EBRT, Brachytherapy) Application (Breast cancer, Lung cancer, Penile cancer, Prostate cancer, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1941.2 million, at a CAGR of 4.34% during the forecast period. The global radiation oncology market is experiencing significant growth due to the increasing incidence and prevalence of cancer cases, particularly in lung, breast, prostate, colorectal, and stomach. This trend is driving the demand for advanced medical procedures to alleviate cancer symptoms or eradicate the disease. Radiation therapy, as a proven treatment approach, is increasingly being adopted to meet this demand. Consequently, the growing need to address the rising incidence of cancer is fueling the expansion of the global radiation oncology market..
Browse market data tables, figures, and in-depth TOC on “Radiation Oncology Market” by Type (EBRT, Brachytherapy) Application (Breast cancer, Lung cancer, Penile cancer, Prostate cancer, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Type, the EBRT segment is projected to dominate the market size in 2024
The Radiation Oncology Market represents a significant business opportunity due to the increasing prevalence of cancer and the growing demand for advanced radiation therapy technologies. Key players in this market include Varian Medical Systems, Elekta AB, and Accuray Incorporated. These companies offer innovative solutions such as Intensity-Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT), driving market growth. The market is expected to expand at a robust CAGR during the forecast period.
By Application, Breast cancer segment is expected to hold the largest market size for the year 2024
In the healthcare sector, the Radiation Oncology Market represents a significant growth opportunity. This market encompasses the production of equipment, technologies, and services essential for delivering radiation therapy to cancer patients. Key trends include the increasing prevalence of cancer, advancements in technology leading to more precise and effective treatments, and growing government support for cancer research and care. Companies in this space must stay abreast of these trends to remain competitive and meet the evolving needs of patients and healthcare providers.
North America is forecasted to hold the largest market size by region in 2024
The Radiation Oncology Market represents a significant business opportunity, driven by the increasing prevalence of cancer and advancements in technology. Providers continue to invest in innovative radiation therapy systems, such as Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Body Radiosurgery (SBRT), to enhance treatment precision and patient outcomes. Market growth is further fueled by regulatory approvals, mergers and acquisitions, and collaborations among key players.
The Radiation Oncology Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Radiation oncology is a subspecialty of oncology that utilizes radiotherapy, or the use of ionizing radiation, to treat cancer. Technological developments in radiation oncology have led to significant therapeutic benefits for patients with various types of cancer, including neuroendocrine cancers, metastatic melanoma, and breast cancer. These advancements include the use of advanced imaging data and treatment planning software to more accurately target tumor cells, as well as innovative radiotherapy devices such as Gamma Knife and Elekta. The global radiation oncology market is expected to grow significantly due to increasing healthcare expenditure on cancer treatment and the rising number of cancer cases. Regulatory scrutiny ensures the safety and efficacy of radiotherapy devices, ensuring that patients receive the best possible care. Oncology research institutes and cancer treatment centers are at the forefront of developing new radiotherapy technologies and techniques, such as proton therapy, to improve cancer treatment outcomes. The therapeutic benefits of radiation oncology continue to make it a crucial component of comprehensive cancer care.
Market Research Overview
Radiation oncology is a specialized field of medicine that utilizes X-Ray machines, linear accelerators, and other radiotherapy devices to target and destroy tumor cells. Technological developments, such as tumor tracking and treatment planning software, have enhanced the therapeutic benefits of radiation therapy, enabling more precise targeting of abnormal cells. Systemic radiotherapy, including radiopharmaceuticals and radioisotopes, also plays a crucial role in cancer treatment. The market for radiation oncology equipment and devices is experiencing significant growth due to rising healthcare spending and the increasing number of cancer cases. Regulatory scrutiny and economic development in emerging nations are also driving demand for advanced radiotherapy systems, such as proton therapy and particle therapy systems. Physicians use various techniques, including external beam radiotherapy (EBRT), intracavitary brachytherapy (IBRT), and stereotactic therapy, to provide curative treatment for a range of cancers, including prostate, breast, brain, head & neck, gynecologic, colorectal, and lung cancer. New technologies, such as IMRT, IGRT, and 4D radiotherapy, offer improved pain reduction and conformal dose delivery. Providers of radiation oncology equipment, such as Elekta, are investing in technological advancements, including the Elekta Unity MR-Linac, which combines magnetic resonance imaging and linear accelerator technology. Cancer treatment centers are adopting these advanced technologies to improve patient outcomes and reduce side effects. Obesity and neuroendocrine cancers, such as metastatic melanoma, present unique challenges in radiation therapy. Innovations in radiation therapy, such as Austrin's afterloaders for Cesium-131 and Curium, are addressing these challenges and expanding the range of curative treatment options. As healthcare expenditure continues to rise and the aging population increases, the adoption rate of radiation oncology technologies is expected to accelerate. The future of radiation oncology lies in the integration of imaging data and advanced technologies to deliver personalized, effective, and safe cancer treatments.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
